Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001580494 | SCV000529443 | likely benign | not provided | 2021-08-05 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000555864 | SCV000651050 | benign | Myofibrillar myopathy 5; Distal myopathy with posterior leg and anterior hand involvement; Hypertrophic cardiomyopathy 26; Dilated Cardiomyopathy, Dominant | 2024-01-24 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001580494 | SCV002545562 | likely benign | not provided | 2023-08-01 | criteria provided, single submitter | clinical testing | FLNC: BP4, BP7, BS1 |
Ambry Genetics | RCV002339061 | SCV002644095 | likely benign | Cardiovascular phenotype | 2019-01-14 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Fulgent Genetics, |
RCV002506056 | SCV002810228 | likely benign | Myofibrillar myopathy 5; Distal myopathy with posterior leg and anterior hand involvement; Hypertrophic cardiomyopathy 26 | 2021-08-18 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV004689737 | SCV005184576 | benign | not specified | 2024-05-26 | criteria provided, single submitter | clinical testing |